InsiderTrades

Form 4 for MRNA Moderna

Accepted 2026-09-08 17:02:21 ET · period of report 2026-09-04 · accession 0001682852-26-000172 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-09-08 17:02 2026-09-04 MRNA Mock James M CFO M - OptEx — +11.8K 80.1K +17% —
D 2026-09-08 17:02 2026-09-04 MRNA Mock James M CFO F - Tax $148.87 -5,704 74.4K -7% -$849.2K
D 2026-09-08 17:02 2026-09-04 MRNA Mock James M CFO M - OptEx $0.00 -11.8K 106.2K -10% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-09-04 M A 11,797 — 80,079 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis. (F1) Restricted stock units convert into common stock on a one-for-one basis.
2 Common Common Stock 2026-09-04 F D 5,704 $148.87 74,375 D — — (F2) Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
3 Derivative Restricted Stock Units 2026-09-04 M D 11,797 $0.00 106,179 D — · — to — 11,797 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) 25% of the shares subject to this restricted stock unit award vested on December 5, 2025, with the remainder vesting in twelve (12) equal quarterly installments thereafter. (F3) 25% of the shares subject to this restricted stock unit award vested on December 5, 2025, with the remainder vesting in twelve (12) equal quarterly installments thereafter.